SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Pension Scheme Deficit

19 Dec 2005 10:25

Rentokil Initial PLC19 December 2005 19 December 2005 RENTOKIL INITIAL plc ADDRESSES PENSION SCHEME DEFICIT In its third quarter update on 3 November 2005, Rentokil Initial plc ("theCompany") announced that it was in discussions with the Trustees of the DefinedBenefit (DB) Sections of the Rentokil Initial Pension Scheme ("the Scheme")regarding measures to address the Scheme's funding deficit and to ensureappropriate future funding levels. These discussions have resulted in thecompany proposing a series of positive steps which will deal with these issuesand protect the security of the Scheme's benefits for its members. The deficit of the UK Scheme under IAS 19 as at 30 November 2005 was estimatedto be £325 million. In response to a general trend of increasing longevity,which has adversely impacted the Scheme, the Company and Trustees have agreed toa more prudent basis for estimating longevity that will increase this deficit byan additional £24 million. An agreement has been reached between the Companyand the Trustees to make an immediate payment of £200 million, with theremaining deficit being met by a series of payments ending no later than January2012. The changed regulatory environment for pensions requires the Company todeal with these issues in a shorter timescale than it might otherwise have done.The total funding required to address the deficit will be in the range of £370million to £380 million depending on the final timing of the payments. In order to reduce the likelihood that the scheme deficit will increasematerially in the future, following discussions with the Company, the Trusteeswill be reviewing the Scheme's investment strategy, with the aim of reducingpotential volatility that might be caused by market movements. This will resultin a lower exposure to equities over time and improve the security of Schemebenefits. With immediate effect, the Company will be entering into a period ofcomprehensive consultation with active members of the DB Sections of the Scheme.The Company is proposing to close the DB Sections for the future accrual ofbenefits for active members. The aim of this is to reduce exposure to futureshortfalls and to ensure that the Scheme will be in a position to continue topay all benefits that have been earned to date by its members. It will alsoprovide the Company with more predictable costs of future pension provision.The proposed closure will have no impact on the scheme's deferred pensioners andpensions in payment. If the Company's proposals are implemented, existing active members of theScheme's DB Sections will be offered membership in a defined contributionarrangement so that they can continue to make provision for retirement. Final decisions regarding the review will be taken once the consultation periodwith active members has been completed later in 2006. Shareholder/analyst enquiriesAndrew Macfarlane, CFO Tel: 01342 833022Lisa Williams, Investor Relations Tel: 01342 833022 Media enquiriesCharles Grimaldi, Corporate Affairs Director Tel: 01342 833022Gill Ackers/Kate Miller, Brunswick Group LLP Tel: 020 7404 5959 Notes to editors: The Defined Benefit Sections of the Rentokil Initial Pension Scheme currentlyhas 3,000 active members, 15,000 deferred pensioners and 8,000 pensions inpayment. At 30 November 2005, the scheme had assets of £640 million and liabilities of£965 million. In the Lane Clark Peacock Accounting for Pensions Annual Survey 2005, RentokilInitial had the 96th lowest level of pension scheme funding out of the FTSE-100. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Jul 20177:00 amRNSAppointment of Non-Executive Director
30th Jun 20178:33 amRNSCompletion of Joint Venture with Haniel
27th Jun 20175:21 pmRNSHolding(s) in Company
26th Jun 20174:54 pmRNSHolding(s) in Company
8th Jun 201711:40 amRNSFurther re Joint Venture with Haniel
7th Jun 20179:41 amRNSDirector Declaration
17th May 20175:02 pmRNSHolding(s) in Company
10th May 20174:31 pmRNSResult of AGM
10th May 20174:03 pmRNSHolding(s) in Company
10th May 201711:49 amRNSAppointment of Senior Independent Director
9th May 20175:51 pmRNSHolding(s) in Company
4th May 20174:44 pmRNSDirector/PDMR Shareholding
26th Apr 20174:27 pmRNSDirector/PDMR Shareholding
25th Apr 20175:58 pmRNSDirector/PDMR Shareholding
21st Apr 20177:00 amRNSRentokil awarded Queen's Award for Enterprise
19th Apr 20177:00 amRNSQ1 Trading Update
5th Apr 201710:43 amRNSAnnual Financial Report
31st Mar 20174:18 pmRNSTotal Voting Rights
30th Mar 20173:25 pmRNSBlock listing Interim Review
22nd Mar 20176:10 pmRNSHolding(s) in Company
9th Mar 20173:06 pmRNSAdditional Listing
28th Feb 20177:00 amRNSRentokil - Leading Pest Control Company in India
24th Feb 20172:37 pmRNSHolding(s) in Company
23rd Feb 20177:00 amRNSFinal Results
7th Feb 20177:00 amRNSAcquisition of Allgood Pest Solutions
29th Dec 20164:30 pmRNSDirector/PDMR Shareholding
16th Dec 20162:59 pmRNSHolding(s) in Company
16th Dec 20162:02 pmRNSHolding(s) in Company
16th Dec 20167:00 amRNSJoint venture with Haniel
7th Dec 20165:47 pmRNSHolding(s) in Company
7th Dec 20167:00 amRNSHolding(s) in Company
18th Nov 20161:15 pmRNSDirector Declaration
11th Nov 20165:30 pmRNSHolding(s) in Company
11th Nov 20165:10 pmRNSTotal Voting Rights
3rd Nov 20161:01 pmRNSDirector Declaration
19th Oct 20167:00 amRNSQ3 Trading Update
6th Oct 20162:58 pmRNSAdditional Listing
6th Oct 201612:31 pmRNSDirector Declaration
4th Oct 20169:49 amRNSDirector Declaration
30th Sep 20162:10 pmRNSTotal Voting Rights
29th Sep 20167:00 amRNSAdditional Listing
26th Sep 20164:48 pmRNSDirector/PDMR Shareholding
22nd Aug 20164:56 pmRNSHolding(s) in Company
28th Jul 20167:00 amRNSHalf Yearly Report
27th Jul 20167:00 amRNSCollaboration with Google and PA Consulting Group
7th Jul 20167:00 amRNSAcquisition, CDC Contract Win and Trading Update
29th Jun 20167:00 amRNSDirectorate Change
29th Jun 20167:00 amRNSDirector/PDMR Shareholding
22nd Jun 20165:27 pmRNSHolding(s) in Company
17th May 20165:06 pmRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.